Do you need to see a specialist for mono? What tests can confirm a diagnosis? And what should you expect when you visit the doctor's office? Get prepared here.
Age, body size and genetics all play roles in who gets testicular cancer. Are you at risk? Learn more about how to avoid testicular cancer risks and its causes.
Alexion Pharmaceuticals Inc. Posted on:23 Sep 11 Soliris, a first-in-class terminal complement inhibitor, specifically targets uncontrolled complement activation, and is indicated for the treatment of patients with aHUS to inhibit complement-mediated TMA.
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals today announced that the European CHMP adopted a positive opinion recommending that Soliris® (eculizumab) be extended to include the treatment of patients with aHUS in Europe.
I learned the ways of canning salsa from a used-car salesman named Roy. He looks like Willie Nelson, bandana and all, and speaks with a southern twang thick enough to get your truck stuck in. ...
Alexion Pharmaceuticals, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved Soliris® (eculizumab) for the treatment of all pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS).